NHL

OncoDaily

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

December, 2024

NHL

Sep 5, 2024, 11:17 | Blog

PentixaFor by Pentixapharm AG receives Orphan Drug Designation for Marginal Zone Lymphoma from the EMA

Pentixapharm Holding AG, the future holding company of Pentixapharm AG, a clinical-stage biotech company discovering…

Jul 29, 2024, 02:16 | Insight

Shahrin Ahmed: A significant increase in the number of clinical trials on Non-Hodgkin's lymphoma since 2019

Shahrin Ahmed, Medical Specialist at the Canadian Cancer Society, shared a post on X: "In 2019,…

Jul 2, 2024, 04:51 | Insight

Frequent IgG testing in CLL and NHL showed reduced rates of infections - ASH

ASH shared a post on X: "A new study in Blood Advances find that patients…

Jun 12, 2024, 22:50 | Blog

Hockey Fights Cancer extends beyond the post-season - National Hockey League

National Hockey League shared on LinkedIn: "Hockey Fights Cancer extends beyond the post-season. The NHL…

All: 4 Posts: 1 - 100

'

Esophageal Cancer: Symptoms, Causes, Stages, Diagnosis & Treatment

'

Faster, Flexible and Affordable: Mikhail Groubman on Building a Global Legacy in Clinical Research in an Untapped Market

'

Invest in Health Policy: A Conversation with Professor Andreas Charalambous

'

FDA Approves Cosibelimab-ipdl for Treatment of Metastatic or Locally Advanced Cutaneous Squamous Cell Carcinoma

'

Dolph Lundgren’s Fight for Life: How He Survived Kidney Cancer After 9 Years of Battle

Special Coverage

ESMO 2024 Congress
September 13-17, 2024
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023